Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

69.16

-1.94 (-2.73%)

At close: Sep 8, 2026, 4:00 PM EDT

68.60

-2.50 (-3.52%)

After-hours: Sep 8, 2026, 7:57 PM EDT

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	36.11	38.52	40.9	50.22	52.28	49.05
Revenue Growth	-7.00%	-5.83%	-18.56%	-3.94%	6.58%	16.30%
Cost of Revenue	15.2	16.52	16.76	20.19	20.09	18.14
Gross Profit	20.91	22	24.14	30.04	32.2	30.92
Selling, General & Admin	8.25	8.58	7.6	12.7	11.91	11.51
Research & Development	0.69	0.67	0.81	0.56	0.49	0.53
Operating Expenses	8.94	9.24	8.41	13.26	12.41	12.04
Operating Income	11.97	12.76	15.73	16.78	19.79	18.88
Interest & Investment Income	2.81	2.81	3.37	3.04	0.66	0.17
Currency Exchange Gain (Loss)	-0.03	-0.02	0	-	-	-
Other Non Operating Income (Expenses)	-0.17	-0.08	-0.16	0.28	0.21	0.02
EBT Excluding Unusual Items	14.59	15.47	18.94	20.09	20.66	19.06
Legal Settlements	-1.7	-1.36	-2.14	-	-	-
Pretax Income	12.89	14.11	16.8	20.09	20.66	19.06
Income Tax Expense	2.4	2.82	2.93	3.45	4.19	4.27
Net Income	10.49	11.29	13.87	16.64	16.47	14.79
Net Income to Common	10.49	11.29	13.87	16.64	16.47	14.79
Net Income Growth	-16.46%	-18.65%	-16.60%	0.98%	11.39%	36.95%
Shares Outstanding (Basic)	3	3	4	4	4	4
Shares Outstanding (Diluted)	3	3	4	4	4	4
Shares Change	-4.75%	-7.51%	-3.68%	-0.17%	-0.46%	-0.33%
EPS (Basic)	3.28	3.48	3.96	4.58	4.53	4.05
EPS (Diluted)	3.28	3.48	3.96	4.57	4.52	4.04
EPS Growth	-12.36%	-12.06%	-13.33%	1.11%	11.88%	37.41%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	11.45	14.32	14.6	21.64	20.34	20.65
Free Cash Flow Per Share	3.58	4.42	4.17	5.95	5.58	5.64
Dividend Per Share	1.235	1.225	1.205	1.185	1.165	0.855
Dividend Growth	1.65%	1.66%	1.69%	1.72%	36.26%	-23.66%
Gross Margin	57.90%	57.12%	59.03%	59.81%	61.58%	63.03%
Operating Margin	33.15%	33.12%	38.46%	33.40%	37.85%	38.49%
Profit Margin	29.04%	29.30%	33.92%	33.12%	31.51%	30.15%
Free Cash Flow Margin	31.70%	37.18%	35.70%	43.09%	38.90%	42.10%
EBITDA	14.37	15.71	18.53	23.09	26.82	26.16
EBITDA Margin	39.79%	40.78%	45.30%	45.98%	51.30%	53.33%
D&A For EBITDA	2.4	2.95	2.8	6.32	7.03	7.28
EBIT	11.97	12.76	15.73	16.78	19.79	18.88
EBIT Margin	33.15%	33.12%	38.46%	33.40%	37.85%	38.49%
Effective Tax Rate	18.61%	20.01%	17.43%	17.19%	20.26%	22.42%

SEC Filings: 10-K · 10-Q